Joon-Yong Chung

42PUBLICATIONS
121CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Powder and particle technologyReaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Jul 28, 2026
Prognostic Value of Exportin-7 and Its Association with KRAS Status and Autophagy Markers in Small Intestinal Adenocarcinoma.

|Jul 01, 2026
Species-specific regulation of necroptosis by STK38-dependent RIPK1 phosphorylation.

|May 25, 2026
Ablation of glypican-3 enhances radiosensitivity in liver cancer by prolonging G2/M arrest and activating the ATM/CHK2 pathway.

|Dec 19, 2025
Coffee Consumption and Colorectal Cancer Survival: A Dose-Response Meta-analysis by Coffee Type and Disease Stage.

Jun-Yeol Kim, Yu-Jin Choi, Yo-Chan Ahn

|Dec 15, 2025
Multimodal Approach for Identification and Validation of Hepatocellular Carcinoma Targets for Radiotheranostics.

Philip Homan, Joon-Yong Chung, Woonghee Lee

|Oct 17, 2025
Diagnosis and Treatment Response Monitoring of Liver Cancer Using Glypican-3-Targeted Single-Domain Antibody PET.

Stanley Fayn, Woonghee Lee, Falguni Basuli

Pageof 7

Frequent Collaborators

10 joint publications

Stephen M Hewitt

5 joint publications

Jaewhan Song

5 joint publications

Hanbyoul Cho

5 joint publications

Freddy E Escorcia